Correlation Between Ocular Therapeutix and Mesoblast

Can any of the company-specific risk be diversified away by investing in both Ocular Therapeutix and Mesoblast at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ocular Therapeutix and Mesoblast into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ocular Therapeutix and Mesoblast, you can compare the effects of market volatilities on Ocular Therapeutix and Mesoblast and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ocular Therapeutix with a short position of Mesoblast. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ocular Therapeutix and Mesoblast.

Diversification Opportunities for Ocular Therapeutix and Mesoblast

-0.62

Correlation Coefficient

Ocular Therapeutix  Mesoblast

Excellent diversification

The 3 months correlation between Ocular and Mesoblast is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Ocular Therapeutix and Mesoblast in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mesoblast and Ocular Therapeutix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ocular Therapeutix are associated (or correlated) with Mesoblast. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mesoblast has no effect on the direction of Ocular Therapeutix i.e., Ocular Therapeutix and Mesoblast go up and down completely randomly.

Pair Corralation between Ocular Therapeutix and Mesoblast

Given the investment horizon of 90 days Ocular Therapeutix is expected to under-perform the Mesoblast. But the stock apears to be less risky and, when comparing its historical volatility, Ocular Therapeutix is 2.15 times less risky than Mesoblast. The stock trades about -0.01 of its potential returns per unit of risk. The Mesoblast is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest  955.00  in Mesoblast on October 8, 2024 and sell it today you would earn a total of  941.00  from holding Mesoblast or generate 98.53% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Ocular Therapeutix  vs.  Mesoblast

Ocular Therapeutix

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Ocular Therapeutix has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Ocular Therapeutix is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.

Mesoblast

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Mesoblast are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent basic indicators, Mesoblast displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Ocular Therapeutix and Mesoblast

The main advantage of trading using opposite Ocular Therapeutix and Mesoblast positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ocular Therapeutix position performs unexpectedly, Mesoblast can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mesoblast will offset losses from the drop in Mesoblast's long position.

The idea behind Ocular Therapeutix and Mesoblast pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.